April 2016: The Goldilocks Hub

Program provides effective, cost-efficient way to help patients overcome affordability barriers and obtain the critical medicines they need.

At the recent CBI Patient Assistance and Access Programs conference in Baltimore, Doyle elaborated on issues related to patient access and education that are causing currents in the traditional patient support models.

How Triplefin’s suite of hub-based e-solutions and customized investments in the “human touch” are outrunning the clock on prior authorization claims-a key source of delays in patient speed to therapy.

In the battle to differentiate a drug from others in the same therapeutic class, it's keeping an "incisive edge" around services delivery that counts.

The Hub-Lite™ model offers an efficient approach to drugs whose cost or pattern of treatment don’t justify the expense of full-fledged patient services.